MBX Biosciences, Inc.
See how your profile stacks up against this role.
We compared the job requirements to your profile to show where you're strong and where you fall short.
Position Summary:
The Vice President, Head of US Pricing & Market Access will lead the development and execution of the U.S. market access strategy to ensure optimal payer coverage, reimbursement, and market access for the company’s portfolio of innovative therapies. Reporting to the Chief Commercial Officer, this executive will build and lead all market access activities, including payer strategy, pricing and contracting, reimbursement, trade and distribution, and health economics and outcomes research (HEOR).
The ideal candidate is a proven market access leader with deep U.S. payer expertise, strong relationships across commercial and government payers, and a successful track record of securing access for specialty and rare disease therapies.
Key Responsibilities:
Strategic Leadership
Payer & Channel Strategy
Trade & Channel Strategy
Evidence & Value Demonstration
Organizational Leadership
Education & Qualifications
Travel & Location
You will be expected to travel periodically, based on business needs, including attending Together Weeks, Together Days, and functional meetings as requested by the Company. This role is expected to be on-site an average of three days per week, unless otherwise requested.
Company Overview:
MBX Biosciences is a biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies based on its proprietary PEP™ platform, for the treatment of endocrine and metabolic disorders. The Company is advancing a pipeline of novel candidates for endocrine and metabolic disorders with clinically validated targets, established endpoints for regulatory approval, significant unmet medical needs and large potential market opportunities. The Company’s pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism preparing for Phase 3 development; and an obesity portfolio that includes MBX 4291 in Phase 1 development and MBX 5765 in preclinical development, as well as additional discovery candidates. The Company is based in Carmel, Indiana and Burlington, Massachusetts. To learn more, please visit the Company website at www.mbxbio.com and follow it on LinkedIn.
EEO Statement:
MBX Biosciences is an Equal Opportunity Employer and is committed to treating all applicants fairly without discrimination. We welcome applications from all individuals, regardless of race, national origin, gender, age, physical characteristics, social origin, disability, union membership, religion, family status, pregnancy, sexual orientation, gender identity, gender expression or any unlawful criterion under applicable law.
After you apply, unlock the direct contact details of the people who actually make the call. A quick follow-up makes you 5x more likely to land an interview.
Marcus Rivera
Chief Revenue Officer

Scowtt Inc

Stormx

Logicalis Asia Pacific

WizeTalent

Dexcom

MBX Biosciences, Inc.